Table 1.
Previously reported procedures for SPE of 5-Fu.
NO. | Solid phase type | Determination technique | Medium | Linearity | LOD | LOQ | Recovery | Ref. |
---|---|---|---|---|---|---|---|---|
1 | OasisWax extraction cartridge | LC-MS/MS | human cultured cellular matrix | 7.5–150 (ng/ml) | - | 7.5 (ng/ml) | 85% | (37) |
3 | Oasis HLB (copolymer of poly(di- vinylbenzene-co-N-vinylpyrrolidone)) cartridge column | LC-MS | human plasma | 0.05–25 (μg/ml) | - | 8.4 (ng/ml) | 73.1–74.8% | (38) |
4 | Isolute ENV+ column | GC–MS/MS | hospital water (waste and surface water) | 2-106 (ng/L) | 0.48 (ng/L) for waste and 0.16 (ng/L) for surface water | 1.6 (ng/L) for waste and 0.54 (ng/L) for surface water | 53% for waste and 93% for surface water | (39) |
5 | ENV+ columns | Capillary electrophoresis | hospital waste water samples | 5–500 (μg/ml) | 1.7 (μg/ml) | 8.6 (μg/ml) | 80–96% | (40) |
6 | Isolute ENV+ cartridges |
GC/MS-MS | hospital waste water | 0.09–40 (μg/L) | 12 (ng/L) | 40 (ng/ml) | 93–101% | (41) |
7 | C18 Chem Elut Cartridge |
HPLC | human plasma | 25–1000 (ng/ml) | - | 20 (ng/ml) | 35% | (42) |
8 | AgNPs@MCM-41-HF | capillary electrophoresis with in-column field-amplified sample injection | Human plasma | 25–1000 (ng/ml) | - | 25 (ng/ml) | 98% | [43] |